Nectar Lifesciences Q1 Results
- BSE: 532649
- NSE: NECLIFE
- ISIN: INE023H01027
- Sector: Biotechnology & Drugs
BSE
10.83
0.26 (2.46%)
0.26 (2.46%)Volume37.27 K
Updated: Tue 6 Oct, 2026 | 15:29:55
NSE
10.720.24 (2.29%)
0.24 (2.29%)Volume3.36 L
Updated: Tue 6 Oct, 2026 | 15:29:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹0.44 Cr.(6917.46%)
- Operating Profit₹-27.38 Cr.(16238.01%)
- Profit After Tax₹-15.72 Cr.(NA%)
- Operating Margin-6193.73%(132.82%)
Note: Comparison is on YoY basis
Quarterly - Nectar Lifesciences Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 27.82 | 146.76 | -81.04% | 334.96 | 15900.35% |
| Depreciation/ Amortization | 0.11 | 0.08 | 32.93% | 15.46 | 27.71% |
| Operating Income | -27.38 | -,145.47 | -81.18% | 24.34 | 16238.01% |
| Net Income | -15.40 | -,360.91 | -95.73% | 2.97 | -75.65% |
| Other Operating Expenses Total | 26.64 | 57.26 | -53.48% | 58.17 | 39715.55% |
| Net Income Before Taxes | -24.62 | -,145.08 | -83.03% | 4.92 | 0.00% |
| Total Revenue | 0.44 | 1.29 | -65.73% | 359.30 | 6917.46% |
| Selling/ General/ Admin Expenses Total | 1.06 | 1.26 | -15.71% | 23.99 | 5114.22% |
| Diluted Normalized EPS | -0.81 | 11.18 | 0.00% | 0.13 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.